Assay News and Research

RSS
Magnitude and durability of SARS-CoV-2 S-binding antibody titers in the pre-variant era among healthcare workers in NYC

Magnitude and durability of SARS-CoV-2 S-binding antibody titers in the pre-variant era among healthcare workers in NYC

SARS-CoV-2 prevalence during the initial period of SARS-CoV-2 Omicron variant emergence in Finland

SARS-CoV-2 prevalence during the initial period of SARS-CoV-2 Omicron variant emergence in Finland

Study shows SARS-CoV-2 antibodies persist for one-year post-infection with protection from other variants

Study shows SARS-CoV-2 antibodies persist for one-year post-infection with protection from other variants

Arrayjet introduces Mercury range of next-generation microarray printers

Arrayjet introduces Mercury range of next-generation microarray printers

Novel rapid genetic test could spare 14,000 newborns from lifelong hearing loss

Novel rapid genetic test could spare 14,000 newborns from lifelong hearing loss

Research demonstrates potential of local siRNA delivery as COVID antiviral therapy in the lung

Research demonstrates potential of local siRNA delivery as COVID antiviral therapy in the lung

Scientists use new CRISPR gene-editing approach to find paths toward possible HIV cure

Scientists use new CRISPR gene-editing approach to find paths toward possible HIV cure

Researchers explore a novel method to isolate monoclonal antibodies from COVID-19 convalescents infected with SARS-CoV-2 variants

Researchers explore a novel method to isolate monoclonal antibodies from COVID-19 convalescents infected with SARS-CoV-2 variants

Study identifies a new class of monoclonal antibodies that neutralize both alpha and beta coronaviruses

Study identifies a new class of monoclonal antibodies that neutralize both alpha and beta coronaviruses

No evidence of SARS-CoV-2 in the U.K.'s wild deer population

No evidence of SARS-CoV-2 in the U.K.'s wild deer population

NIH program provides a real-time risk assessment of variants of SARS-CoV-2

NIH program provides a real-time risk assessment of variants of SARS-CoV-2

The mucosal antibody response to SARS-CoV-2

The mucosal antibody response to SARS-CoV-2

Novaplex real-time PCR assays can reliably, rapidly  detect SARS-CoV-2 in patient samples

Novaplex real-time PCR assays can reliably, rapidly detect SARS-CoV-2 in patient samples

Scientists explore impact of SARS-CoV-2 natural immunity on vaccine-induced immunity

Scientists explore impact of SARS-CoV-2 natural immunity on vaccine-induced immunity

Messenger ribonucleic acid boosters shown to be effective against Omicron infections in mice

Messenger ribonucleic acid boosters shown to be effective against Omicron infections in mice

Common coronavirus infections don't generate antibodies that effectively cross-react with SARS-CoV-2

Common coronavirus infections don't generate antibodies that effectively cross-react with SARS-CoV-2

Chemical in leafy greens could prevent infections by coronaviruses including SARS-CoV-2

Chemical in leafy greens could prevent infections by coronaviruses including SARS-CoV-2

Study analyzed several naturally-occurring amino acid variations found in the extended loop harboring the SARS-CoV-2 S1/S2 cleavage site

Study analyzed several naturally-occurring amino acid variations found in the extended loop harboring the SARS-CoV-2 S1/S2 cleavage site

Antiviral functions of interferon regulatory factors during human coronavirus infection

Antiviral functions of interferon regulatory factors during human coronavirus infection

Divalent SARS-CoV-2 fusion vaccine found to be effective in mice

Divalent SARS-CoV-2 fusion vaccine found to be effective in mice

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.